News Releases

$

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Hero Chart
- Unaudited estimated total LIVMARLI net product revenue of $3.0 million for fourth quarter 2021. - Preliminary cash, cash equivalents, and short-term investments of $261.5 million as of December 31, 2021 . FOSTER CITY, Calif. --(BUSINESS WIRE)--Jan. 11, 2022-- Mirum Pharmaceuticals, Inc.
... Read More
Additional Formats
FOSTER CITY, Calif. --(BUSINESS WIRE)--Jan. 10, 2022-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on January 10, 2022 , the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 51,700 shares of
... Read More
Additional Formats
FOSTER CITY, Calif. --(BUSINESS WIRE)--Jan. 4, 2022-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will present at the annual J.P. Morgan Healthcare Conference taking place virtually January 10-13, 2022 . Chris Peetz , Mirum’s president and chief executive officer, will
... Read More
Additional Formats